Argenx Se (ARGX) Invested Capital (2015 - 2018)

Argenx Se (ARGX) posted quarterly Invested Capital of $31.2 million for Q2 2018, up 40.98% on a QoQ basis from $22.1 million in Q4 2017.

Argenx Se (ARGX) Invested Capital (2015 - 2018) Analysis & Trends

Argenx Se (ARGX) has reported Invested Capital for 4 consecutive years, with $31.2 million the latest figure, recorded in Q2 2018.

  • Quarterly Invested Capital changed N/A year-over-year to $31.2 million in Q2 2018, while the trailing twelve-month figure through Mar 2019 was $31.2 million (up 40.98% YoY) and the FY2017 annual result came in at $22.1 million, up 25.57% from the prior year.
  • Invested Capital advanced to $31.2 million in Q2 2018 per ARGX's latest filing, from $22.1 million in the prior quarter.
  • Over the last five years, Invested Capital for ARGX reached as high as $31.2 million in Q2 2018 and fell as low as $6.6 million in Q4 2015.
  • A 4-year average of $19.3 million and a median of $19.8 million in 2017 frame the typical range for Invested Capital.
  • Annual changes were most pronounced in 2016 — Invested Capital surged 168.37% — and 2017, when it rose 25.57%.
  • Year by year, Invested Capital stood at $6.6 million in 2015, then jumped by 168.37% to $17.6 million in 2016, then increased by 25.57% to $22.1 million in 2017, then soared by 40.98% to $31.2 million in 2018.
  • According to Business Quant data, Invested Capital over the past three periods registered $31.2 million, $22.1 million, and $17.6 million for Q2 2018, Q4 2017, and Q4 2016 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.96 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 116.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2018 31.15 Mn
Dec 31, 2017 22.10 Mn
Dec 31, 2016 17.60 Mn
Dec 31, 2015 6.56 Mn